No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Trastuzumab emtansine monotherapy is noninferior to standard neoadjuvant therapy for ERBB2+ breast cancer

byTeddy Guo

September 8, 2021

in StudyGraphics

Reading Time: 1 min read

#VisualAbstract: Efficacy and safety of adalimumab in conjunction with surgery in moderate to severe hidradenitis suppurativa

RelatedReports

Sleep duration, sleepiness, chronotype have variable associations with teen self-regulation

Weekly Rewinds

2 Minute Medicine Rewind August 10, 2026

August 10, 2026

Nivolumab may be effective in platinum-resistant ovarian cancer

Surgery

Perioperative toripalimab improves event-free survival in non-small cell lung cancer

August 9, 2026

Variability in interpretation of breast biopsy slides associated with low verification of atypia and ductal carcinoma in situ

Chronic Disease

A digital mental health intervention may improve anxiety in breast cancer survivors

July 31, 2026

Weekly Rewinds

2 Minute Medicine Rewind July 27th, 2026

July 27, 2026

Updated USPSTF guidelines favor treatment of mild gestational diabetes

Novel macrophage-regulating cream demonstrated superior therapeutic efficacy for the treatment of diabetic foot ulcers compared to standard absorbent dressing

$The STORM trial: treatment refractory multiple myeloma patients experience response with selinexor$

Biologic teclistamab shows promise in treatment of refractory multiple myeloma in phase 1 drug study

Association of sleep duration with all-cause mortality in East Asian adults

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports